Zilver® PTX® in China

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

Also called NCT02171962

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 178 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02171962
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02171962. Allocation not applicable; no masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Zilver® PTX® in China
Condition
Peripheral Artery Disease
Intervention (Device)
Zilver® PTX® Drug-Eluting Peripheral Stent
Lead sponsor
Cook Group Incorporated (class: industry)

Record details

Record id
cardio:ct-nct02171962
Content hash
d75f0336ad645f3cc495d55c6cedb719e520c282643d696bfd9928d9eb204806